Monitoring ALC in the first 14 days post-cilta cel infusion may help identify patients with RRMM who are at high risk of developing neurocognitive TEAEs and cranial nerve palsy. Measuring certain ...
The analysis of 11,427 Veterans Administration (VA) hospital patients with multiple myeloma (MM) reveals that lymphopenia affects 53% of patients at diagnosis. The median overall survival was 2.7 ...
Please provide your email address to receive an email when new articles are posted on . Lymphopenia at diagnosis or during follow-up can predict OS among patients with multiple myeloma. Researchers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback